Check out the newly published guideline for using Bisphosphonates and Denosumab in managing patients with malignant bone pain

You can now access our NICE accredited guideline on the Use of Bisphosphonates and Denosumab for the Management of Malignant Bone Pain. This new  guideline now replaces the 2009 edition.

There is lots of helpful information on:

-how they work

-when and which to use,

-doses , routes of administration,  infusion rates

-side effects and how to manage them and much more

There is a Quick Reference Summary to help although we would always recommend reading the full guideline.

We hope that you will  find them helpful in every day clinical practice and we would be delighted to hear any feedback that you would like to share with us

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.